Free Trial

BeiGene (BGNE) SEC Filings & 10K Form

$152.17
+1.67 (+1.11%)
(As of 07/12/2024 08:51 PM ET)

Recent BeiGene SEC Filings

DateFilerForm TypeView
07/03/2024
4:05 PM
BeiGene (Issuer)
Wang Julia Aijun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:18 PM
BeiGene (Subject)
Wang Julia Aijun (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
4:22 PM
BeiGene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
4:24 PM
BeiGene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
4:25 PM
BeiGene (Issuer)
Wang Lai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
4:26 PM
BeiGene (Issuer)
Wang Julia Aijun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:30 PM
BeiGene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:19 PM
BeiGene (Subject)
Wang Julia Aijun (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:23 PM
BeiGene (Subject)
Wu Xiaobin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:25 PM
BeiGene (Subject)
Wang Lai (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
4:27 PM
BeiGene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:24 PM
BeiGene (Issuer)
Lee Chan Henry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:25 PM
BeiGene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:25 PM
BeiGene (Issuer)
Wang Lai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:26 PM
BeiGene (Issuer)
Wang Julia Aijun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:50 PM
BeiGene (Subject)
Wang Lai (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:50 PM
BeiGene (Subject)
Wang Lai (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:53 PM
BeiGene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:57 PM
BeiGene (Subject)
Wang Julia Aijun (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
4:01 PM
BeiGene (Issuer)
BRANDICOURT OLIVIER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:02 PM
BeiGene (Issuer)
Dugan Margaret (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:03 PM
BeiGene (Issuer)
Lee Chan Henry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:03 PM
BeiGene (Issuer)
Wang Lai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:04 PM
BeiGene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:05 PM
Ball Titus B. (Reporting)
BeiGene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:31 PM
BeiGene (Issuer)
Yi Qingqing (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:23 PM
BeiGene (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/05/2024
3:35 PM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:25 PM
BeiGene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
5:06 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
5:09 AM
BeiGene (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:21 PM
BeiGene (Filer)
Form ARS
04/26/2024
3:16 PM
BeiGene (Filer)
Form DEF 14A
04/26/2024
6:15 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:13 PM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
3:27 PM
BeiGene (Filer)
Form PRE 14A
04/11/2024
5:01 PM
BeiGene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:21 PM
BeiGene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
4:26 PM
Ball Titus B. (Reporting)
BeiGene (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2024
3:10 PM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
4:23 PM
BeiGene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
New Government Policy to Wipe Out Seniors Wealth (Ad)

Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.

Click Here To Get Your FREE Guide Now!
03/13/2024
4:04 PM
BeiGene (Issuer)
Glazer Donald W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
5:01 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
5:16 AM
BeiGene (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2024
5:02 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
3:12 PM
BeiGene (Subject)
OYLER JOHN (Filed by)
Form SC 13G/A
01/23/2024
5:03 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
5:01 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
4:44 PM
BeiGene (Issuer)
Wang Xiaodong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
4:54 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
BeiGene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
5:48 PM
Baker Brothers Life Sciences LP (Reporting)
BeiGene (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2023
5:49 PM
667, L.P. (Reporting)
BeiGene (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
3:31 PM
BeiGene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/20/2023
3:04 PM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2023
3:04 PM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2023
5:01 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2023
5:23 AM
BeiGene (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2023
5:13 AM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2023
3:50 PM
BeiGene (Subject)
Lee Chan Henry (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/24/2023
3:13 PM
BeiGene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BGNE) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners